X4 Pharmaceuticals Inc (XFOR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2019 | 12-2018 | 12-2017 | 12-2016 | 12-2015 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -52,807 | -33,285 | -21,994 | -22,975 | -13,218 |
| Depreciation Amortization | 103 | 103 | 71 | 285 | 389 |
| Accounts receivable | N/A | N/A | N/A | 152 | -56 |
| Accounts payable and accrued liabilities | -2,752 | 1,307 | -1,169 | 1,264 | 77 |
| Other Working Capital | -3,236 | 3,135 | 642 | -517 | 1,447 |
| Other Operating Activity | 10,637 | 3,320 | 1,139 | 152 | 545 |
| Operating Cash Flow | $-48,055 | $-25,420 | $-21,311 | $-21,639 | $-10,816 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | 826 | N/A | -378 | -73 | -170 |
| Net Acquisitions | 26,406 | N/A | N/A | N/A | N/A |
| Other Investing Activity | 0 | 0 | 0 | 0 | -77 |
| Investing Cash Flow | $27,232 | $N/A | $-378 | $-73 | $-247 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | N/A | N/A | 5,500 | 4,000 |
| Debt Issued | 9,849 | 9,908 | 6,000 | 7,514 | 1,527 |
| Debt Repayment | -9,368 | -6,380 | 0 | -250 | -1,000 |
| Common Stock Issued | 140,180 | 7 | 9 | N/A | 16 |
| Other Financing Activity | 0 | 3,335 | 27,413 | 5,383 | 6,962 |
| Financing Cash Flow | $140,661 | $6,870 | $33,422 | $18,147 | $11,505 |
| Exchange Rate Effect | -250 | N/A | N/A | -103 | -122 |
| Beginning Cash Position | 8,498 | 27,048 | 15,315 | 7,097 | 6,439 |
| End Cash Position | 128,086 | 8,498 | 27,048 | 3,429 | 6,759 |
| Net Cash Flow | $119,588 | $-18,550 | $11,733 | $-3,668 | $320 |
| Free Cash Flow | |||||
| Operating Cash Flow | -48,055 | -25,420 | -21,311 | -21,639 | -10,816 |
| Capital Expenditure | -174 | N/A | -378 | -73 | -170 |
| Free Cash Flow | -48,229 | -25,420 | -21,689 | -21,712 | -10,986 |